-
Subject Areas on Research
-
17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
-
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
-
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.
-
2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
-
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
-
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
-
5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.
-
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial.
-
A Preliminary Investigation of a Relapse Prevention Mobile Application to Maintain Smoking Abstinence Among Individuals With Posttraumatic Stress Disorder.
-
A Smart and Multifaceted Mobile Health System for Delivering Evidence-Based Secondary Prevention of Stroke in Rural China: Design, Development, and Feasibility Study.
-
A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease.
-
A freeze on tailored antiplatelet therapy?
-
A mathematical model to evaluate the routine use of fecal microbiota transplantation to prevent incident and recurrent Clostridium difficile infection.
-
A motivational intervention can improve retention in PCIT for low-motivation child welfare clients.
-
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
-
Achievement of guideline-concordant care and in-hospital outcomes in patients with coronary artery disease in teaching and nonteaching hospitals: results from the Get With The Guidelines-Coronary Artery Disease program.
-
Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children.
-
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
-
Acute upper airway angioedema secondary to acquired C1 esterase inhibitor deficiency: a case report.
-
Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks.
-
Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
-
Adjuvant therapy after surgical stone management.
-
Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies.
-
Advances in Stroke: Treatments-Preventive.
-
Advances in opioid antagonist treatment for opioid addiction.
-
Advances in stroke: Prevention and health services delivery 2012-2013.
-
Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time.
-
Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation.
-
American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care.
-
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States.
-
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
-
Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association).
-
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
-
Antiplatelet Use and Ischemic Stroke Risk in Minor Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the POINT Trial.
-
Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoring.
-
Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
-
Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure.
-
Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis.
-
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial.
-
Applying the evidence in coronary disease secondary prevention: a call to action.
-
Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational data.
-
Assessing the preventive effects of cognitive therapy following relief of depression: A methodological innovation.
-
Association between early postoperative nutritional supplement utilisation and length of stay in malnourished hip fracture patients.
-
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.
-
Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.
-
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
-
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes.
-
Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study.
-
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.
-
Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.
-
B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
-
Balancing the risks and benefits of long-term antiplatelet therapies for cardiovascular disease: clinical, research, and regulatory implications.
-
Barriers to medication adherence in a rural-urban dual economy: a multi-stakeholder qualitative study.
-
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
-
Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients.
-
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.
-
Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.
-
Beyond the Window: Patient Characteristics and Geographic Locations Associated with Late Prenatal Care in Women Eligible for 17-P Preterm Birth Prevention.
-
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.
-
Bipolar arthroplasty for recurrent total hip instability.
-
Broad spectrum triazoles for invasive mould infections in adults: Which drug and when?
-
Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay.
-
Can involuntary outpatient commitment reduce hospital recidivism?: Findings from a randomized trial with severely mentally ill individuals.
-
Can my patient dive after a first episode of primary spontaneous pneumothorax? A systematic review of the literature.
-
Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy.
-
Care of the Pediatric Patient on Chronic Dialysis.
-
Centers for Medicare and Medicaid Services' Decision to Reconsider Coverage Indications for ICDs: Where to Now?
-
Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.
-
China's response to the rising stroke burden.
-
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
-
Chronic kidney disease and stroke.
-
Chronic myelogenous leukemia.
-
Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial.
-
Clinical risk factors for recurrent fracture after hip fracture: a prospective study.
-
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.
-
Clinical use of nefazodone in major depression: a 6-year perspective.
-
Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
-
Cognitive Processing Therapy or Relapse Prevention for comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A randomized clinical trial.
-
Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability.
-
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
-
Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review.
-
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
-
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS).
-
Comprehensive Stroke Care and Outcomes: Time for a Paradigm Shift.
-
Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety.
-
Contemporary Reflections on the Safety of Long-Term Aspirin Treatment for the Secondary Prevention of Cardiovascular Disease.
-
Contemporary approach to the diagnosis and management of non-ST-segment elevation acute coronary syndromes.
-
Contemporary therapy of acute ST-elevation myocardial infarction.
-
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
-
Coronary intervention for persistent occlusion after myocardial infarction.
-
Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.
-
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.
-
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
-
Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
-
Death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic stroke-longitudinal registry.
-
Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5-Year Experience.
-
Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study.
-
Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
-
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
-
Designing mental health interventions informed by child development and human biology theory: a social ecology intervention for child soldiers in Nepal.
-
Differences in health care use and outcomes by the timing of in-hospital worsening heart failure.
-
Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
-
Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis.
-
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial.
-
Drug delivery and therapeutic impact of extended-release acetylsalicylic acid.
-
Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial.
-
Edoxaban in the secondary prevention of VTE.
-
Effect and neural mechanisms of the transcutaneous vagus nerve stimulation for relapse prevention in patients with remitted major depressive disorder: protocol for a longitudinal study.
-
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
-
Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients With Acute Ischemic Stroke in China: A Randomized Clinical Trial.
-
Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy.
-
Effectiveness of a primary care-based integrated mobile health intervention for stroke management in rural China (SINEMA): A cluster-randomized controlled trial.
-
Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction.
-
Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial.
-
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment.
-
Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
-
Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies.
-
Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
-
Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.
-
Efficacy of a Nurse-Delivered Intervention to Prevent and Delay Postpartum Return to Smoking: The Quit for Two Trial.
-
Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease.
-
Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
-
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
-
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
-
Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm.
-
Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
-
Elective stoma construction improves outcomes in medically intractable pressure ulcers.
-
Engaging the Entire Care Cascade in Western Kenya: A Model to Achieve the Cardiovascular Disease Secondary Prevention Roadmap Goals.
-
Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators.
-
Eosinophilic granuloma. A different behaviour in children than in adults.
-
Etanercept plus standard therapy for Wegener's granulomatosis.
-
Evaluating the impact of pharmacists in mental health: a systematic review.
-
Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke.
-
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
-
Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events.
-
Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks.
-
Fibrinolysis for acute myocardial infarction: the future is here and now.
-
First-line pharmacotherapy approaches for generalized anxiety disorder.
-
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.
-
Folic acid supplementation and chronic kidney disease progression.
-
Foot and Ankle Surgery: Common Problems and Solutions.
-
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.
-
From the editor: Confronting a pandemic or two.
-
Future directions in research on psychotherapy for adolescent depression.
-
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
-
Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders.
-
Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.
-
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.
-
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
-
High-dose atorvastatin after stroke or transient ischemic attack.
-
Highlights in ASCVD Primary Prevention for 2021.
-
Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality.
-
How much can be gained by more systematic prevention of stroke?
-
Impact of Cardiac Rehabilitation and Exercise Training on Psychological Risk Factors and Subsequent Prognosis in Patients With Cardiovascular Disease.
-
Impact of Secondary Prevention in an Occupational High-Risk Group.
-
Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction.
-
Importance and Challenges of Moving Stroke Prevention into the Community.
-
In-Hospital Outcomes and Discharge Medication Use Among Patients With Critical Limb Ischemia Versus Claudication.
-
In-hospital worsening heart failure.
-
Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers.
-
Incidence and predictors of microbiology results returning postdischarge and requiring follow-up.
-
Incorporating primary and secondary prevention approaches to address childhood obesity prevention and treatment in a low-income, ethnically diverse population: study design and demographic data from the Texas Childhood Obesity Research Demonstration (TX CORD) study.
-
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial.
-
Indicators of pretreatment suicidal ideation in adults with major depressive disorder.
-
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.
-
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
-
Insights on the robust variance estimator under recurrent-events model.
-
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
-
International consensus statement on major depressive disorder.
-
Interventions for suicidal youth: a review of the literature and developmental considerations.
-
Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial.
-
Intravitreal bevacizumab for macular edema due to central retinal vein occlusion: perfused vs. ischemic and early vs. late treatment.
-
Investigational drugs in phase II clinical trials for acute coronary syndromes.
-
Is there a definition of remission in late-life depression that predicts later relapse?
-
Is there a role for continuation phase cognitive therapy for depressed outpatients?
-
Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death.
-
Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study.
-
Kinetics of hepatitis C virus reinfection after liver transplantation.
-
Lessons learned from a clinical trial.
-
Lipid Testing and Statin Dosing After Acute Myocardial Infarction.
-
Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations.
-
Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care.
-
Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
-
Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
-
Low back pain.
-
Maintenance of Weight Loss After Initiation of Nutrition Training: A Randomized Trial.
-
Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study.
-
Major depressive disorder treatment guidelines in America and Europe.
-
Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association.
-
Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
-
Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement.
-
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.
-
Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
-
Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry.
-
Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
-
Naltrexone in patients with bipolar disorder and alcohol dependence.
-
No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants.
-
Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.
-
Opportunities for improving use of evidence-based therapy in patients with type 2 diabetes and cardiovascular disease.
-
Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.
-
Oral anticoagulant therapy for the prevention of stroke.
-
Oral cleft prevention program (OCPP).
-
Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial.
-
Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry.
-
Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
-
P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.
-
PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study.
-
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
-
Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
-
Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care.
-
Patient-Informed Treatment Development of Behavioral Smoking Cessation for People With Schizophrenia.
-
Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
-
Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.
-
Pharmacologic treatment of acute and chronic stress following trauma: 2006.
-
Pharmacotherapy of social anxiety disorder: what does the evidence tell us?
-
Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
-
Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
-
Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study.
-
Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.
-
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.
-
Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients.
-
Predictive relationships between chronic pain and negative emotions: a 4-month daily process study using Therapeutic Interactive Voice Response (TIVR).
-
Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.
-
Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer.
-
Prevention of restenosis: medical treatment and procedures for iliac occlusive disease.
-
Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin's lymphoma: cost-effectiveness analyses.
-
Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia.
-
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?
-
Public health clinical demonstration project for smoking cessation in american veterans who served since september 11, 2001.
-
Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials.
-
Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
-
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
-
Racial differences in persistence to secondary prevention medication regimens after ischemic stroke.
-
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide.
-
Randomized trial on mindfulness training for smokers targeted to a disadvantaged population.
-
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial.
-
Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction.
-
Rationale and design of the AngeLmed for Early Recognition and Treatment of STEMI trial: a randomized, prospective clinical investigation.
-
Re: Early Physical Therapy for Acute Low Back Pain May Not Reduce Health Services Utilization, Costs, and Opioid Use.
-
Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.
-
Reexamination of the Embolic Stroke of Undetermined Source Concept.
-
Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines--Stroke 2003-2010.
-
Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
-
Relapse following combined treatment discontinuation in a placebo-controlled trial for panic disorder.
-
Relapse of depression after electroconvulsive therapy.
-
Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial.
-
Religiosity as a protective factor in depressive disorder.
-
Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?
-
Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated Collection.
-
Representation of women in randomized clinical trials of cardiovascular disease prevention.
-
Research Priorities in the Secondary Prevention of Atrial Fibrillation: A National Heart, Lung, and Blood Institute Virtual Workshop Report.
-
Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals?
-
Restenosis rates following vertebral artery origin stenting: does stent type make a difference?
-
Return to play and physical performance tests: evidence-based, rough guess or charade?
-
Rheumatic Heart Disease in the Twenty-First Century.
-
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
-
Risk factor profile and management of cerebrovascular patients in the REACH Registry.
-
Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.
-
Risks versus benefits of different types of long-acting injectable antipsychotics.
-
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
-
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.
-
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
-
Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.
-
Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer.
-
STAR*D: what have we learned?
-
Safety and efficacy outcomes of left atrial posterior wall isolation compared to pulmonary vein isolation and pulmonary vein isolation with linear ablation for the treatment of persistent atrial fibrillation.
-
Secondary Prevention Risk Interventions via Telemedicine and Tailored Patient Education (SPRITE): A randomized trial to improve post myocardial infarction management.
-
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).
-
Secondary Prevention, Not Secondary Importance: Embracing Survivorship Concerns and HRT After Cervical Cancer Radiation Therapy.
-
Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice.
-
Secondary prevention of cardiovascular diseases in India: Findings from registries and large cohorts.
-
Secondary prevention of ischaemic stroke: more evidence to block two pathways affecting platelet activation.
-
Secondary prevention risk interventions via telemedicine and tailored patient education (SPRITE): a randomized trial to improve postmyocardial infarction management.
-
Secondary prevention shifts into second gear.
-
Secondary preventive medication persistence and adherence 1 year after stroke.
-
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
-
Severe primary refractory thrombotic thrombocytopenic purpura (TTP) in the post plasma exchange (PEX) and rituximab era.
-
Sex Differences in the Use of Statins in Community Practice.
-
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
-
Sildenafil: Possible Prophylaxis against Swimming-induced Pulmonary Edema.
-
Similar secondary stroke prevention and medication persistence rates among rural and urban patients.
-
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.
-
Star-D: lessons learned and future implications.
-
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
-
Statins for Primary Prevention in Older Adults: An Unresolved Conundrum.
-
Strategies and tactics in the management of maintenance treatment for depressed patients.
-
Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial.
-
Stress alleviation and reward enhancement: two promising targets for relapse prevention.
-
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.
-
Stroke Prevention in Patients with Patent Foramen Ovale.
-
Survival After Secondary Prevention Implantable Cardioverter-Defibrillator Placement: An Analysis From the NCDR ICD Registry.
-
Survival is not the only valuable end point in melanoma screening.
-
System-integrated technology-enabled model of care (SINEMA) to improve the health of stroke patients in rural China: Statistical analysis plan for a cluster-randomized controlled trial.
-
System-integrated technology-enabled model of care to improve the health of stroke patients in rural China: protocol for SINEMA-a cluster-randomized controlled trial.
-
Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.
-
Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
-
Targeted interventions to prevent transitioning from acute to chronic low back pain in high-risk patients: development and delivery of a pragmatic training course of psychologically informed physical therapy for the TARGET trial.
-
Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
-
The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease.
-
The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics.
-
The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trial.
-
The STAR*D Project results: a comprehensive review of findings.
-
The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial.
-
The Urinary Microbiome in Postmenopausal Women with Recurrent Urinary Tract Infections.
-
The comparison of epicardial focused ultrasound circumferential pulmonary vein ablation and BOX ablation--results from experimental acute atrial fibrillation.
-
The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.
-
The future of clinical trials in secondary prevention after acute coronary syndromes.
-
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.
-
Therapeutic Interactive Voice Response for chronic pain reduction and relapse prevention.
-
Therapy for ocular toxoplasmosis.
-
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry.
-
Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
-
Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials.
-
Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis.
-
Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release.
-
Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
-
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
-
Tobacco smoking and other suspected antecedents of nonmedical psychostimulant use in the United States, 1995.
-
Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention.
-
Transcatheter closure of patent foramen ovale following cryptogenic stroke: An updated meta-analysis of randomized controlled trials.
-
Transition of care for acute stroke and myocardial infarction patients: from hospitalization to rehabilitation, recovery, and secondary prevention.
-
Translating the Secondary Prevention Therapeutic Boom Into Action.
-
Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack.
-
Treatment Strategies for Deficiency of Adenosine Deaminase 2.
-
Treatment of Recurrent Electrographic Nonconvulsive Seizures (TRENdS) study.
-
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
-
Trends in outcomes among older patients with non-ST-segment elevation myocardial infarction.
-
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
-
Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health.
-
Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice.
-
Use of beta-blockers in patients with an implantable cardioverter defibrillator.
-
Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial.
-
Using Telehealth to Disseminate Primary, Secondary, and Tertiary CVD Interventions to Rural Populations.
-
Venous ulcer diagnosis, treatment, and prevention of recurrences.
-
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
-
Vorapaxar in the secondary prevention of atherothrombosis.
-
Vorapaxar in the secondary prevention of atherothrombotic events.
-
Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial.
-
Warfarin or aspirin for recurrent ischemic stroke.
-
Women's resources and use of strategies as risk and protective factors for reabuse over time.
-
Keywords of People